Ginkgo Bioworks Holdings (DNABW) Change in Accured Expenses (2020 - 2026)

Ginkgo Bioworks Holdings has reported Change in Accured Expenses for 7 years, with the latest figure at -$11.6 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 230.8% year-over-year to -$11.6 million; the trailing twelve-month figure through Mar 2026 stood at -$10.1 million (up 76.22% YoY), and the FY2025 full-year result was $10.4 million, up 125.66% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$11.6 million, down from -$6.6 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $22.1 million in Q3 2025, with the low at -$42.0 million in Q3 2024.
• Historically, Change in Accured Expenses has averaged -$3.8 million across 5 years, with a median of -$818000.0 in 2023.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 178.17% — and 2025, when it slumped 199814.29%.
• Ginkgo Bioworks Holdings' Change in Accured Expenses stood at -$27.8 million in 2022, then jumped by 178.17% to $21.7 million in 2023, then sank by 143.0% to -$9.3 million in 2024, then rose by 29.17% to -$6.6 million in 2025, then slumped by 75.37% to -$11.6 million in 2026.
• The last three Change in Accured Expenses figures came in at -$11.6 million (Q1 2026), -$6.6 million (Q4 2025), and $22.1 million (Q3 2025), per Business Quant data.